Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M196,265Revenue $M51,584Net Margin (%)18.4Z-Score0
Enterprise Value $M196,265EPS $3.2Operating Margin %25.2F-Score0
P/E(ttm))22.0Cash Flow Per Share $3.5Pre-tax Margin (%)24.7Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %3.0Quick Ratio0Cash flow > EarningsN
Price/Sales4.15-y EBITDA Growth Rate %2.3Current Ratio0Lower Leverage y-yN
Price/Cash Flow7.2y-y EBITDA Growth Rate %-25.0ROA % (ttm)6.4Higher Current Ratio y-yN
Dividend Yield %3.3Insider Buy (3m)0ROE % (ttm)14.2Less Shares Outstanding y-yN
Payout Ratio %63.0Shares Outstanding M6,301ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEVanguard Health Care Fund 2014-12-31 Add0.32%$27.7 - $32.09
($30.23)
$ 31.253%Add 29.88%19,395,622
PFEIrving Kahn 2014-09-30 Reduce-0.59%$28.04 - $30.96
($29.58)
$ 31.256%Reduce -6.56%1,985,161
PFEMichael Price 2014-09-30 Reduce-0.22%$28.04 - $30.96
($29.58)
$ 31.256%Reduce -56.02%47,100
PFEJean-Marie Eveillard 2014-09-30 Reduce-0.16%$28.04 - $30.96
($29.58)
$ 31.256%Reduce -94.11%135,661
PFERay Dalio 2014-09-30 Reduce-0.02%$28.04 - $30.96
($29.58)
$ 31.256%Reduce -24.91%295,108
PFEHOTCHKIS & WILEY 2014-09-30 Sold Out -0.01%$28.04 - $30.96
($29.58)
$ 31.256%Sold Out0
PFEVanguard Health Care Fund 2014-06-30 Add0.62%$29.02 - $32.4
($30.05)
$ 31.254%Add 105.23%14,934,022
PFEJoel Greenblatt 2014-06-30 Add0.27%$29.02 - $32.4
($30.05)
$ 31.254%Add 71.59%1,741,314
PFECharles Brandes 2014-06-30 Add0.12%$29.02 - $32.4
($30.05)
$ 31.254%Add 5.78%6,075,460
PFERay Dalio 2014-06-30 Add0.06%$29.02 - $32.4
($30.05)
$ 31.254%Add 250.56%393,008
PFEMichael Price 2014-06-30 Reduce-0.97%$29.02 - $32.4
($30.05)
$ 31.254%Reduce -69.14%107,100
PFENWQ Managers 2014-06-30 Reduce-0.81%$29.02 - $32.4
($30.05)
$ 31.254%Reduce -31.07%6,363,006
PFEDodge & Cox 2014-06-30 Reduce-0.5%$29.02 - $32.4
($30.05)
$ 31.254%Reduce -23.73%48,902,097
PFEJean-Marie Eveillard 2014-06-30 Reduce-0.47%$29.02 - $32.4
($30.05)
$ 31.254%Reduce -70.71%2,303,762
PFEJohn Hussman 2014-06-30 Sold Out -0.04%$29.02 - $32.4
($30.05)
$ 31.254%Sold Out0
PFEHOTCHKIS & WILEY 2014-06-30 Reduce-0.01%$29.02 - $32.4
($30.05)
$ 31.254%Reduce -33.68%128,800
PFEIrving Kahn 2014-03-31 Add0.98%$29.66 - $32.75
($31.36)
$ 31.250%Add 11.22%2,112,819
PFEJoel Greenblatt 2014-03-31 Add0.38%$29.66 - $32.75
($31.39)
$ 31.250%Add 356.54%1,014,808
PFEJohn Hussman 2014-03-31 Buy 0.04%$29.66 - $32.75
($31.36)
$ 31.250%New holding, 17000 sh.17,000
PFEVanguard Health Care Fund 2014-03-31 Reduce-0.48%$29.66 - $32.75
($31.36)
$ 31.250%Reduce -40.13%7,276,622
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PFE Brian Rogers 2014-12-3112,737,1150.21.4
PFE Ken Fisher 2014-12-3131,196,4150.52-1.6%
PFE David Dreman 2014-09-3015,04000.04+10.47%
PFE John Keeley 2014-09-3097,33900.06+8.35%
PFE Charles Brandes 2014-09-306,257,0900.12.5+2.99%
PFE James Barrow 2014-09-3062,170,8810.992.5+2.76%
PFE Ken Fisher 2014-09-3031,702,4950.52+0.7%
PFE Robert Bruce 2014-09-30452,0000.013.7
PFE Vanguard Health Care Fund 2014-09-3014,934,0220.241.1
PFE Prem Watsa 2014-09-30235,00000.47
PFE Ruane Cunniff 2014-09-3010,96700-0.18%
PFE NWQ Managers 2014-09-306,338,4580.12-0.39%
PFE Dodge & Cox 2014-09-3047,604,9800.761.3-2.65%
PFE Ronald Muhlenkamp 2014-09-3039,49900.21-3.71%
PFE Irving Kahn 2014-09-301,985,1610.039.5-6.56%
PFE Joel Greenblatt 2014-09-301,622,0920.030.48-6.85%
PFE Mario Gabelli 2014-09-301,023,5810.020.16-7.29%
PFE Ray Dalio 2014-09-30295,10800.07-24.91%
PFE Michael Price 2014-09-3047,10000.17-56.02%
PFE Jean-Marie Eveillard 2014-09-30135,66100.01-94.11%
PFE HOTCHKIS & WILEY 2014-09-30000Sold Out
PFE Mark Hillman 2013-12-3123,98201.1
Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MADDALUNA ANTHONY JExecutive Vice President 2014-12-08Sell6,500$32-0.53view
HILL CHARLES HExecutive Vice President 2014-11-10Sell8,285$30.185.47view
DAMELIO FRANK AExecutive Vice President 2014-11-07Sell0$29.786.88view
YOUNG JOHN DGroup President 2014-11-07Sell21,600$29.896.49view
READ IAN CChairman & CEO 2014-10-30Sell67,500$29.766.96view
MADDALUNA ANTHONY JExecutive Vice President 2014-10-29Sell2,425$29.567.68view
OLSON LAURIE JExecutive Vice President 2014-06-12Sell36,275$29.537.79view
Germano Geno JGroup President 2014-06-02Sell30,000$29.687.24view
YOUNG JOHN DGroup President 2014-03-17Sell9,000$31.381.43view
PFIZER INC10% Owner 2014-03-12Buy272,727$11189.36view

Press Releases about PFE :

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Pfizer Stock Ready For New Highs Jan 28 2015 
    Pharmaceuticals Sector To See High Voltage Action in 2015 Jan 23 2015 
    Gilead Sciences Still has More Upside Jan 22 2015 
    Johnson & Johnson Riding High On Ebola Vaccines Jan 21 2015 
    Pfizer Stocks Has A Lot Of Steam To Take The Investors Higher Jan 20 2015 
    jan15 Jan 10 2015 
    mom Dec 27 2014 
    Pfizer Spreading Its Wings Into A New Domain Of Life Sciences Dec 09 2014 
    Zoetis in a Growing Global Animal Health Industry Dec 03 2014 
    Guru Ken Fisher’s Top Five Quarterly Stocks Nov 16 2014 


    More From Other Websites
    Cramer: Uncertainty breeding cloud of fear Jan 29 2015
    OPKO and Pfizer Receive Regulatory Clearance for Global Agreement Jan 29 2015
    OPKO and Pfizer Receive Regulatory Clearance for Global Agreement Jan 29 2015
    No Signs of Weakness at Facebook, But Shares Still Too Pricey Jan 29 2015
    Reputation Management With Digital And Social Media Jan 29 2015
    Pfizer Will Do Fine Without AstraZeneca Jan 28 2015
    Blue chip blues Jan 28 2015
    Stock Market News for January 28, 2015 - Market News Jan 28 2015
    Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Jan 28 2015
    [$$] Pfizer Hit by Stronger Dollar, Patent Losses Jan 28 2015
    Drug Firms Report Good Q4, But Outlook Cloudy Jan 27 2015
    Cramer: Wouldn't you rather own a winner than a whiner? Jan 27 2015
    Pfizer to Pay $400M to Settle Shareholder Suit Over Off-Label Marketing Jan 27 2015
    Dow ends down 291 on earnings misses Jan 27 2015
    Pfizer's 2015 forecast disappoints, crimped by generics, dollar Jan 27 2015
    Pfizer to pay $400 million to avert investor class action trial Jan 27 2015
    Strong Dollar Means Flabby Outlook For Some Overseas Jan 27 2015
    PFIZER INC (PFE) Earnings Report: Q4 2014 Conference Call Transcript Jan 27 2015
    Pfizer chief says big acquisition not required Jan 27 2015
    Pfizer net down on lower sales, higher research, legal costs Jan 27 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    SEENSCO
    ReplySEENSCO - 7 months ago
    PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK